Works matching IS 00302414 AND DT 2021 AND VI 99 AND IP 10
Results: 9
Front & Back Matter.
- Published in:
- Oncology, 2021, v. 99, n. 10, p. 1, doi. 10.1159/000519738
- Publication type:
- Article
Retreatment of Irinotecan in Later Lines of Therapy for Metastatic Colorectal Cancer: A Retrospective Study.
- Published in:
- Oncology, 2021, v. 99, n. 10, p. 665, doi. 10.1159/000518041
- By:
- Publication type:
- Article
Influence of Baseline Positron Emission Tomography in Metastatic Gastroesophageal Cancer on Survival and Response to Therapy.
- Published in:
- Oncology, 2021, v. 99, n. 10, p. 659, doi. 10.1159/000517842
- By:
- Publication type:
- Article
Response to Immune Checkpoint Inhibitors in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma May Be Affected by Tumor Sites.
- Published in:
- Oncology, 2021, v. 99, n. 10, p. 652, doi. 10.1159/000517738
- By:
- Publication type:
- Article
Lenvatinib for Hepatocellular Carcinoma Patients with Nonviral Infection Who Were Unlikely to Respond to Immunotherapy: A Retrospective, Comparative Study.
- Published in:
- Oncology, 2021, v. 99, n. 10, p. 641, doi. 10.1159/000517494
- By:
- Publication type:
- Article
The Rise of the TROP2-Targeting Agents in NSCLC: New Options on the Horizon.
- Published in:
- Oncology, 2021, v. 99, n. 10, p. 673, doi. 10.1159/000517438
- By:
- Publication type:
- Article
Lymphocyte-to-Monocyte Ratio Is a Predictive Biomarker of Response to Treatment with Nivolumab for Gastric Cancer.
- Published in:
- Oncology, 2021, v. 99, n. 10, p. 632, doi. 10.1159/000517344
- By:
- Publication type:
- Article
First Report of Oncological Outcome and Prognostic Analysis in a First-Line Setting of Short Hydration Gemcitabine and Cisplatin Chemotherapy for Patients with Metastatic Urothelial Carcinoma.
- Published in:
- Oncology, 2021, v. 99, n. 10, p. 622, doi. 10.1159/000517326
- By:
- Publication type:
- Article
Pretreatment Positron Emission Tomography with <sup>18</sup>F-Fluorodeoxyglucose May Be a Useful New Predictor of Overall Prognosis Following Lenvatinib Treatment.
- Published in:
- Oncology, 2021, v. 99, n. 10, p. 611, doi. 10.1159/000516565
- By:
- Publication type:
- Article